Takayasu Arteritis Clinical Trial in China
NCT02981979
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
116
Enrollment
OTHER
Sponsor class
Conditions
Takayasu Arteritis
Interventions
DRUG:
Leflunomide(LEF)
DRUG:
Prednisone Acetate Tablets
DRUG:
Placebos
Sponsor
Jiang lindi